ArticleParasite (Paris, France)2026
Genetic characterisation of Cryptosporidium spp., Encephalitozoon spp., and Enterocytozoon bieneusi in European brown hare (Lepus europaeus) in Central Europe.
Article in Parasite (Paris, France), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The European brown hare (Lepus europaeus) is an ecologically important small game mammal whose populations have declined in many European countries. A total of 370 faecal samples collected between 2022 and 2024 from hares in the Czechia and Slovakia were molecularly screened for the presence of Cryptosporidium spp. (18S rRNA, gp60), Giardia intestinalis (TPI), Encephalitozoon spp., and Enterocytozoon bieneusi (ITS). qPCR analysis confirmed the presence of Cryptosporidium spp. (n = 15; 4.1%; CI: 2.5-6.6%), Encephalitozoon spp. (n = 34; 9.2%; CI: 6.7-12.6%), and E. bieneusi (n = 16; 4.3%; CI: 2.6-6.9%). Sequence analyses revealed the presence of C. parvum (n = 2), C. sciurinum (n = 3), C. ubiquitum (n = 5), and Cryptosporidium sp. deer mouse genotype IV (n = 5). At the gp60 locus, C. parvum belonged to subtypes IIaA15G1R1 and IIaA23G1R1, C. sciurinum to subtypes VIIIcA10G2R1 (n = 2) and VIIIbA11G1R1 (n = 1), and C. ubiquitum to subtypes XIIa (n = 3) and XIId (n = 2). Five E. bieneusi genotypes were identified: D (n = 8), CHALT1 (n = 1), WildBoar3 (n = 1), CHN-F1 (n = 2), and C (n = 4). Encephalitozoon sequencing revealed E. cuniculi genotypes I (n = 6), II (n = 26), and III (n = 1), and E. hellem (n = 1). Giardia intestinalis was not detected. Cryptosporidium sp. deer mouse genotype IV is reported here for the first time in Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.